OncoSil Medical Ltd (ASX: $OSL) has requested an immediate trading halt pending an announcement related to a potential capital raise. The halt will remain in place until the company makes an announcement regarding the outcome of the potential capital raising, expected before the commencement of normal trading on Wednesday, 20 March 2024, or until the market opens on Wednesday, 20 March 2024, whichever is earlier.
In accordance with ASX Listing Rule 17.1, OncoSil Medical Ltd (ASX: $OSL) has requested a trading halt to facilitate the announcement of a potential capital raise. The company aims to inform the market about the outcome of the capital raising before the specified timeline. The request has been made in compliance with the regulatory requirements, and the company is not aware of any reason why the trading halt request should not be granted.
OncoSil Medical Ltd (ASX: $OSL) has requested a trading halt in line with ASX Listing Rule 17.1 to prepare for a potential capital raise announcement. The company anticipates providing the market with details regarding the outcome of the capital raising before the specified timeline. The request has been made in adherence to regulatory obligations, and the company has expressed its lack of awareness of any reason why the trading halt request should not be granted. The trading halt will be in place until the announcement is made or the market opens on Wednesday, 20 March 2024.
Good news as they now need to expand given the treatment works well.